Fin-X is a technology company.
Fin-X has raised $4.0M across 2 funding rounds.
Fin-X has raised $4.0M in total across 2 funding rounds.
Fin-X has raised $4.0M in total across 2 funding rounds.
Fin-X's investors include DOMO Invest, Headline (formerly e.ventures).
Fin-X is a Brazil-based technology platform that automates surgical scheduling and streamlines healthcare operations for hospitals and providers.[1][4] It integrates real-time data management, process control, and business intelligence to reduce manual workloads, cut costs, minimize fraud and waste, and improve transparency, ultimately broadening patient access to services.[1] Targeting hospitals and medical professionals facing inefficiencies in resource management and scheduling, Fin-X has secured over $2M in funding, signaling strong early growth in the healthtech space.[1]
The platform digitizes processes, connects healthcare stakeholders, and provides tools for performance analysis, addressing core pain points like delays and opacity in surgical workflows.[1][4]
Fin-X emerged from the inefficiencies plaguing Brazilian healthcare, particularly manual surgical scheduling that leads to delays, higher costs, and poor resource allocation.[1] Based in São Paulo, Brazil, the company developed as a response to these systemic challenges, focusing on automation and real-time data to empower providers.[1] Early traction is evident from its $2M+ funding and profiles on startup platforms, marking it as a promising healthtech player with pivotal emphasis on operational digitization.[1]
Specific founder details are not detailed in available sources, but the platform's design reflects deep domain knowledge in healthcare revenue cycles and efficiency.[4]
These features position Fin-X as a specialized SaaS tool tailored for surgical operations, distinct from broader healthtech by its narrow focus on scheduling precision.[1]
Fin-X rides the global healthtech wave of digital transformation, amplified in emerging markets like Brazil where manual healthcare processes hinder scalability.[1] Timing aligns with post-pandemic demands for efficient resource allocation and telehealth integration, as hospitals prioritize automation amid rising surgical backlogs and cost pressures.[1][4] Market forces favoring it include Brazil's expanding healthtech investments and regulatory pushes for transparency, enabling Fin-X to influence ecosystem-wide efficiency by standardizing data flows among providers.[1]
By bridging operational gaps, it contributes to broader trends in AI-assisted healthcare and revenue cycle management, potentially scaling to Latin American markets.[1][4]
Fin-X is poised for expansion through deeper hospital integrations and potential AI enhancements for predictive scheduling, capitalizing on its funding momentum.[1] Trends like generative AI for healthcare analytics and regional healthtech funding surges will shape its path, possibly evolving it into a full revenue-cycle suite.[1][4] Its influence could grow by setting standards for surgical tech in Brazil, fostering a more connected ecosystem—echoing its core mission to automate and humanize healthcare access from the outset.[1]
Fin-X has raised $4.0M across 2 funding rounds. Most recently, it raised $2.0M Venture Round in April 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2025 | $2.0M Venture Round | DOMO Invest, Headline (formerly e.ventures) | |
| Mar 1, 2023 | $2.0M Seed | DOMO Invest, Headline (formerly e.ventures) |